- Home
- INTA vs HTFL Comparison
INTA vs HTFL Comparison
Compare INTA & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INTA | HTFL |
|---|---|---|
| Founded | 2000 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.2B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | INTA | HTFL |
|---|---|---|
| Price | $22.81 | $31.37 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $46.75 | $38.20 |
| AVG Volume (30 Days) | 771.0K | ★ 1.5M |
| Earning Date | 05-05-2026 | 05-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $504,120,000.00 | N/A |
| Revenue This Year | $15.91 | $27.66 |
| Revenue Next Year | $13.78 | $23.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.09 | N/A |
| 52 Week Low | $19.24 | $20.13 |
| 52 Week High | $58.79 | $41.22 |
Technical Indicators
Market Signals| Indicator | INTA | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 44.09 | 73.17 |
| Support Level | $20.76 | $28.86 |
| Resistance Level | $26.51 | $32.52 |
| Average True Range (ATR) | 1.39 | 1.52 |
| MACD | 0.00 | 0.55 |
| Stochastic Oscillator | 45.59 | 95.54 |
Price Performance
Historical ComparisonAbout INTA Intapp Inc.
Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital,g, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.
About HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.